[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![HighSell53466 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1937749820602753024.png) Buy High Sell Low [@HighSell53466](/creator/twitter/HighSell53466) on x XXX followers
Created: 2025-07-19 16:24:48 UTC

$VKTX is chasing $LLY and $NVO—but it’s not just another GLP-1 player.

$VKTX focuses on small-molecule oral drugs.
$NVO and $LLY dominate with injectables and first-mover advantage.
$VKTX has upside if oral options gain traction—especially for patients wary of needles.
Risk? $VKTX is still pre-revenue.

The underdog bet in a heavyweight market.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946607161976484202/c:line.svg)

**Related Topics**
[drugs](/topic/drugs)
[$nvobut](/topic/$nvobut)
[$lly](/topic/$lly)
[$vktx](/topic/$vktx)
[eli lilly](/topic/eli-lilly)
[stocks healthcare](/topic/stocks-healthcare)
[$nvo](/topic/$nvo)

[Post Link](https://x.com/HighSell53466/status/1946607161976484202)